119 related articles for article (PubMed ID: 23227781)
1. Discovery of agonists of cannabinoid receptor 1 with restricted central nervous system penetration aimed for treatment of gastroesophageal reflux disease.
Plowright AT; Nilsson K; Antonsson M; Amin K; Broddefalk J; Jensen J; Lehmann A; Jin S; St-Onge S; Tomaszewski MJ; Tremblay M; Walpole C; Wei Z; Yang H; Ulander J
J Med Chem; 2013 Jan; 56(1):220-40. PubMed ID: 23227781
[TBL] [Abstract][Full Text] [Related]
2. Aminopyrazine CB1 receptor inverse agonists.
Wustrow DJ; Maynard GD; Yuan J; Zhao H; Mao J; Guo Q; Kershaw M; Hammer J; Brodbeck RM; Near KE; Zhou D; Beers DS; Chenard BL; Krause JE; Hutchison AJ
Bioorg Med Chem Lett; 2008 Jun; 18(11):3376-81. PubMed ID: 18448340
[TBL] [Abstract][Full Text] [Related]
3. Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration.
Dziadulewicz EK; Bevan SJ; Brain CT; Coote PR; Culshaw AJ; Davis AJ; Edwards LJ; Fisher AJ; Fox AJ; Gentry C; Groarke A; Hart TW; Huber W; James IF; Kesingland A; La Vecchia L; Loong Y; Lyothier I; McNair K; O'Farrell C; Peacock M; Portmann R; Schopfer U; Yaqoob M; Zadrobilek J
J Med Chem; 2007 Aug; 50(16):3851-6. PubMed ID: 17630726
[TBL] [Abstract][Full Text] [Related]
4. Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist.
Jensen J; Lehmann A; Uvebrant A; Carlsson A; Jerndal G; Nilsson K; Frisby C; Blackshaw LA; Mattsson JP
Eur J Pharmacol; 2005 Sep; 519(1-2):154-7. PubMed ID: 16102747
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists.
Meurer LC; Finke PE; Mills SG; Walsh TF; Toupence RB; Debenham JS; Goulet MT; Wang J; Tong X; Fong TM; Lao J; Schaeffer MT; Chen J; Shen CP; Sloan Stribling D; Shearman LP; Strack AM; Van der Ploeg LH
Bioorg Med Chem Lett; 2005 Feb; 15(3):645-51. PubMed ID: 15664830
[TBL] [Abstract][Full Text] [Related]
6. Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.
Yan L; Huo P; Debenham JS; Madsen-Duggan CB; Lao J; Chen RZ; Xiao JC; Shen CP; Stribling DS; Shearman LP; Strack AM; Tsou N; Ball RG; Wang J; Tong X; Bateman TJ; Reddy VB; Fong TM; Hale JJ
J Med Chem; 2010 May; 53(10):4028-37. PubMed ID: 20423086
[TBL] [Abstract][Full Text] [Related]
7. 4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.
Procopiou PA; Ancliff RA; Bamford MJ; Browning C; Connor H; Davies S; Fogden YC; Hodgson ST; Holmes DS; Looker BE; Morriss KM; Parr CA; Pickup EA; Sehmi SS; White GV; Watts CJ; Wilson DM; Woodrow MD
J Med Chem; 2007 Dec; 50(26):6706-17. PubMed ID: 18052318
[TBL] [Abstract][Full Text] [Related]
8. Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation.
Lehmann A; Antonsson M; Aurell-Holmberg A; Blackshaw LA; Brändén L; Elebring T; Jensen J; Kärrberg L; Mattsson JP; Nilsson K; Oja SS; Saransaari P; von Unge S
Br J Pharmacol; 2012 Mar; 165(6):1757-1772. PubMed ID: 21950457
[TBL] [Abstract][Full Text] [Related]
9. 6-Alkoxy-5-aryl-3-pyridinecarboxamides, a new series of bioavailable cannabinoid receptor type 1 (CB1) antagonists including peripherally selective compounds.
Röver S; Andjelkovic M; Bénardeau A; Chaput E; Guba W; Hebeisen P; Mohr S; Nettekoven M; Obst U; Richter WF; Ullmer C; Waldmeier P; Wright MB
J Med Chem; 2013 Dec; 56(24):9874-96. PubMed ID: 24175572
[TBL] [Abstract][Full Text] [Related]
10. 2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.
Zhou D; Gross JL; Adedoyin AB; Aschmies SB; Brennan J; Bowlby M; Di L; Kubek K; Platt BJ; Wang Z; Zhang G; Brandon N; Comery TA; Robichaud AJ
J Med Chem; 2012 Mar; 55(5):2452-68. PubMed ID: 22313242
[TBL] [Abstract][Full Text] [Related]
11. Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice.
Lehmann A; Holmberg AA; Bhatt U; Bremner-Danielsen M; Brändén L; Elg S; Elebring T; Fitzpatrick K; Geiss WB; Guzzo P; Jensen J; Jerndal G; Mattsson JP; Nilsson K; Olsson BM
Br J Pharmacol; 2005 Sep; 146(1):89-97. PubMed ID: 15980875
[TBL] [Abstract][Full Text] [Related]
12. Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.
Lange JH; van Stuivenberg HH; Coolen HK; Adolfs TJ; McCreary AC; Keizer HG; Wals HC; Veerman W; Borst AJ; de Looff W; Verveer PC; Kruse CG
J Med Chem; 2005 Mar; 48(6):1823-38. PubMed ID: 15771428
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives.
Lange JH; Kruse CG
Chem Rec; 2008; 8(3):156-68. PubMed ID: 18563799
[TBL] [Abstract][Full Text] [Related]
14. 1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.
Micheli F; Bonanomi G; Blaney FE; Braggio S; Capelli AM; Checchia A; Curcuruto O; Damiani F; Fabio RD; Donati D; Gentile G; Gribble A; Hamprecht D; Tedesco G; Terreni S; Tarsi L; Lightfoot A; Stemp G; Macdonald G; Smith A; Pecoraro M; Petrone M; Perini O; Piner J; Rossi T; Worby A; Pilla M; Valerio E; Griffante C; Mugnaini M; Wood M; Scott C; Andreoli M; Lacroix L; Schwarz A; Gozzi A; Bifone A; Ashby CR; Hagan JJ; Heidbreder C
J Med Chem; 2007 Oct; 50(21):5076-89. PubMed ID: 17867665
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
Chen RZ; Frassetto A; Lao JZ; Huang RR; Xiao JC; Clements MJ; Walsh TF; Hale JJ; Wang J; Tong X; Fong TM
Eur J Pharmacol; 2008 Apr; 584(2-3):338-42. PubMed ID: 18336811
[TBL] [Abstract][Full Text] [Related]
16. Reflux inhibitors: a new approach for GERD?
Boeckxstaens GE
Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
[TBL] [Abstract][Full Text] [Related]
17. Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.
Liu P; Lin LS; Hamill TG; Jewell JP; Lanza TJ; Gibson RE; Krause SM; Ryan C; Eng W; Sanabria S; Tong X; Wang J; Levorse DA; Owens KA; Fong TM; Shen CP; Lao J; Kumar S; Yin W; Payack JF; Springfield SA; Hargreaves R; Burns HD; Goulet MT; Hagmann WK
J Med Chem; 2007 Jul; 50(15):3427-30. PubMed ID: 17608398
[TBL] [Abstract][Full Text] [Related]
18. Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists.
Chu GH; Saeui CT; Worm K; Weaver DG; Goodman AJ; Broadrup RL; Cassel JA; DeHaven RN; LaBuda CJ; Koblish M; Brogdon B; Smith S; Le Bourdonnec B; Dolle RE
Bioorg Med Chem Lett; 2009 Oct; 19(20):5931-5. PubMed ID: 19736007
[TBL] [Abstract][Full Text] [Related]
19. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
[TBL] [Abstract][Full Text] [Related]
20. Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel.
Bilodeau MT; Balitza AE; Koester TJ; Manley PJ; Rodman LD; Buser-Doepner C; Coll KE; Fernandes C; Gibbs JB; Heimbrook DC; Huckle WR; Kohl N; Lynch JJ; Mao X; McFall RC; McLoughlin D; Miller-Stein CM; Rickert KW; Sepp-Lorenzino L; Shipman JM; Subramanian R; Thomas KA; Wong BK; Yu S; Hartman GD
J Med Chem; 2004 Dec; 47(25):6363-72. PubMed ID: 15566305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
